National drug policies to local formulary decisions in Thailand, China, and Australia: Drug listing changes and opportunities

Yoongthong, Worasuda, Hu, Shanlian, Whitty, Jennifer A., Wibulpolprasert, Suwit, Sukantho, Kitti, Thienthawee, Wannisa, Han, Huixue and Scuffham, Paul A. (2012) National drug policies to local formulary decisions in Thailand, China, and Australia: Drug listing changes and opportunities. Value in Health, 15 (1). S126-S131. ISSN 1098-3015

Full text not available from this repository. (Request a copy)

Abstract

This commentary is aimed at summarizing the second plenary session presented at the ISPOR 4th Asia-Pacific Conference held in 2010 and compare the issues on drug listing of Thailand, China, and Australia. These countries have substantially different demographic and economic characteristics and health-care financing structures and are in different phases of development of health technology assessment (HTA) (Table 1). Expenditure data shown in Table 1 for 2008 were converted at purchasing power parity to US dollars.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Economics Faculty of Medicine and Health Sciences > Research Groups > Respiratory and Airways Group Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	Pure Connector
Date Deposited:	27 Apr 2016 14:00
Last Modified:	06 Feb 2025 06:22
URI:	https://ueaeprints.uea.ac.uk/id/eprint/58438
DOI:	10.1016/j.jval.2011.11.003

Actions (login required)

View Item